透景生命
(300642)
| 流通市值：19.18亿 | | | 总市值：22.71亿 |
| 流通股本：1.38亿 | | | 总股本：1.63亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 74,893,130.45 | 436,781,430.69 | 320,918,983.86 | 215,670,657.94 |
| 营业收入 | 74,893,130.45 | 436,781,430.69 | 320,918,983.86 | 215,670,657.94 |
| 利息收入 | 0 | - | - | 0 |
| 已赚保费 | 0 | - | - | 0 |
| 手续费及佣金收入 | 0 | - | - | 0 |
| 二、营业总成本 | 73,541,389.21 | 373,365,191.17 | 287,293,766.22 | 196,175,478.64 |
| 营业成本 | 27,214,482.93 | 147,867,692.12 | 112,516,196.45 | 78,614,052.81 |
| 税金及附加 | 794,556.43 | 4,875,234.6 | 3,476,294.48 | 2,282,908.28 |
| 销售费用 | 25,885,452.21 | 130,716,399.68 | 98,234,190.04 | 67,088,558.95 |
| 管理费用 | 9,927,386.91 | 31,516,158.24 | 25,769,232.43 | 17,282,852.43 |
| 研发费用 | 11,057,969.71 | 65,722,373.17 | 49,460,725.22 | 33,231,174.95 |
| 财务费用 | -1,338,458.98 | -7,332,666.64 | -2,162,872.4 | -2,324,068.78 |
| 其中:利息费用 | 149,372.76 | 500,088.71 | 374,949.21 | 242,267.35 |
| 其中:利息收入 | 1,537,586.52 | 7,899,422.57 | 3,504,090.71 | 2,477,770.12 |
| 加:公允价值变动收益 | 461,964.39 | -173,036.11 | 902,357.76 | 495,432.83 |
| 加:投资收益 | 1,680,393.05 | -9,376,386.55 | 1,508,551.44 | 710,885.13 |
| 汇兑收益 | 0 | - | - | 0 |
| 资产处置收益 | -10,174.45 | 4,082,665.37 | 1,065,805.64 | -137,912.39 |
| 资产减值损失(新) | 0 | -11,165,136.41 | -6,879,986.46 | -6,879,986.46 |
| 信用减值损失(新) | -5,589,479.03 | -16,092,645.15 | -10,237,654.36 | -10,046,358.45 |
| 其他收益 | 1,021,615.65 | 7,935,221.76 | 3,585,049.97 | 907,743.02 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -1,083,939.15 | 38,626,922.43 | 23,569,341.63 | 4,544,982.98 |
| 加:营业外收入 | 5,715.27 | 86,359.19 | 86,356.19 | 86,356.17 |
| 减:营业外支出 | 511.65 | 2,949,434.48 | 1,124,028.07 | 993,901.1 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -1,078,735.53 | 35,763,847.14 | 22,531,669.75 | 3,637,438.05 |
| 减:所得税费用 | -154,497.33 | 7,387,100.66 | 2,764,059.22 | 73,321.01 |
| 六、净利润 | -924,238.2 | 28,376,746.48 | 19,767,610.53 | 3,564,117.04 |
| 持续经营净利润 | -924,238.2 | 28,376,746.48 | 19,767,610.53 | 3,564,117.04 |
| 归属于母公司股东的净利润 | 471,691.09 | 34,534,995.78 | 24,392,882.81 | 6,633,992.8 |
| 少数股东损益 | -1,395,929.29 | -6,158,249.3 | -4,625,272.28 | -3,069,875.76 |
| (一)基本每股收益 | 0 | 0.21 | 0.15 | 0.04 |
| (二)稀释每股收益 | 0 | 0.21 | 0.15 | 0.04 |
| 八、其他综合收益 | 250,585.36 | -3,702,354.65 | 229,161.46 | -294,248.6 |
| 归属于母公司股东的其他综合收益 | 250,585.36 | -3,702,354.65 | 229,161.46 | -294,248.6 |
| 九、综合收益总额 | -673,652.84 | 24,674,391.83 | 19,996,771.99 | 3,269,868.44 |
| 归属于母公司股东的综合收益总额 | 722,276.45 | 30,832,641.13 | 24,622,044.27 | 6,339,744.2 |
| 归属于少数股东的综合收益总额 | -1,395,929.29 | -6,158,249.3 | -4,625,272.28 | -3,069,875.76 |
| 公告日期 | 2025-04-28 | 2025-04-19 | 2024-10-25 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |